Back to Results
First PageMeta Content
Yeasts / Antifungals / Fungal diseases / Echinocandins / Pfizer / Candida krusei / Fungemia / Candidiasis / Anidulafungin / Biology / Mycology / Microbiology


Anidulafungin_rationale_2 0_2013
Add to Reading List

Document Date: 2013-02-27 05:49:38


Open Document

File Size: 93,08 KB

Share Result on Facebook

Company

J Clin Pharm / /

Continent

Europe / /

Country

Germany / Switzerland / Norway / Belgium / Turkey / France / Austria / Netherlands / Italy / Sweden / Finland / Spain / Greece / Denmark / /

IndustryTerm

anidulafungin / /

MedicalCondition

HIV / deep-seated organ infection / human infections / Clinical data Invasive candidiasis / neutropenia / candidiasis / serious infections / abscesses / invasive candidiasis / deep-seeded organ infection / breakthrough infections / /

MedicalTreatment

intravenous therapy / /

Organization

European Society for Clinical Microbiology and Infectious Diseases / EUCAST MIC / European Centre for Disease Prevention and Control / European Society for Clinical Microbiology / European Committee on Antimicrobial Susceptibility Testing / Infectious Diseases / /

Person

Candida spp / Candida glabrata / /

Position

General / /

Product

fluconazole / /

Technology

Pharmacokinetics / Pharmacodynamics / /

URL

http /

SocialTag